Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
ISL1 cardiovascular progenitor cells for cardiac repair after myocardial infarction
Oscar Bartulos, … , Jordan S. Pober, Yibing Qyang
Oscar Bartulos, … , Jordan S. Pober, Yibing Qyang
Published July 7, 2016
Citation Information: JCI Insight. 2016;1(10):e80920. https://doi.org/10.1172/jci.insight.80920.
View: Text | PDF
Research Article Cardiology Neuroscience Stem cells Transplantation Vascular biology

ISL1 cardiovascular progenitor cells for cardiac repair after myocardial infarction

  • Text
  • PDF
Abstract

Cardiovascular progenitor cells (CPCs) expressing the ISL1-LIM–homeodomain transcription factor contribute developmentally to cardiomyocytes in all 4 chambers of the heart. Here, we show that ISL1-CPCs can be applied to myocardial regeneration following injury. We used a rapid 3D methylcellulose approach to form murine and human ISL1-CPC spheroids that engrafted after myocardial infarction in murine hearts, where they differentiated into cardiomyocytes and endothelial cells, integrating into the myocardium and forming new blood vessels. ISL1-CPC spheroid–treated mice exhibited reduced infarct area and increased blood vessel formation compared with control animals. Moreover, left ventricular (LV) contractile function was significantly better in mice transplanted with ISL1-CPCs 4 weeks after injury than that in control animals. These results provide proof-of-concept of a cardiac repair strategy employing ISL1-CPCs that, based on our previous lineage-tracing studies, are committed to forming heart tissue, in combination with a robust methylcellulose spheroid–based delivery approach.

Authors

Oscar Bartulos, Zhen Wu Zhuang, Yan Huang, Nicole Mikush, Carol Suh, Alda Bregasi, Lin Wang, William Chang, Diane S. Krause, Lawrence H. Young, Jordan S. Pober, Yibing Qyang

×

Figure 7

Colocalization of RAC1 and IQGAP1 and cadherin expression during human ISL1-CPC spheroid formation.

Options: View larger image (or click on image) Download as PowerPoint
Colocalization of RAC1 and IQGAP1 and cadherin expression during human I...
(A) Staining for RAC1, IQGAP1, and phalloidin in control- or Y27632-treated hISL1-CPCs 2 hours after cell plating during spheroid formation. Note the colocalization of RAC1, IQGAP1, and actin in Y27632-treated cells in the cell-cell contact regions. Arrowheads show the absence of RAC1 in the membrane of cells treated with vehicle control. Scale bars: 20 μm. (B) Spheroid formation 48 hours after hISL1-CPCs plating in the presence of Y27632 or Y27632 + 2.5 mM EGTA. Scale bar: 100 μm. (C) Cadherin gene expression by qPCR. DSG1; Desmoglein 1. n = 4 (Mann-Whitney U test). *P < 0.05. (D) Staining for N-cadherin, hypophospho β-catenin, and phalloidin in control- or Y27632-treated hISL1-CPCs 8 hours after cell plating during spheroid formation. Scale bars: 20 μm.

Copyright © 2025 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts